Evidence
Front Neuroendocrinol. 2023 May 21:101078. doi: 10.1016/j.yfrne.2023.101078. Online ahead of print.
ABSTRACT
Bipolar disorder is a decidedly heterogeneous and multifactorial disease, with significant psychosocial and medical disease burden. Much difficulty has been encountered in developing novel therapeutics and objective biomarkers for clinical use in this population. In that regard, gut-microbial homeostasis appears to modulate several key pathways relevant to a variety of psychiatric, metabolic, and inflammatory disorders. Microbial impact on immune, endocrine, endocannabinoid, kynurenine, and other pathways are discussed throughout this review. Emphasis is placed on this system’s relevance to current pharmacology, diet, and comorbid illness in bipolar disorder. Despite the high level of optimism promoted in many reviews on this topic, substantial obstacles exist before any microbiome-related findings can provide meaningful clinical utility. Beyond a comprehensive overview of pathophysiology, this review hopes to highlight several key areas where progress is needed. As well, novel microbiome-associated suggestions are presented for future research.
PMID:37220806 | DOI:10.1016/j.yfrne.2023.101078
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
The Role of the Gut Microbiome in Bipolar Disorder and its Common Comorbidities
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- A comprehensive review on the pharmacological role of gut microbiome in neurodegenerative disorders: potential therapeutic targets
- Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
- Bipolar disorder and the gut microbiota: a bibliometric analysis
- Bipolar disorder and the gut microbiota: a bibliometric analysis
- A metagenome-wide association study of gut microbiome in patients with AMD, ASD, RA, T2D & VKH diseases
- Deciphering the therapeutic potential of SheXiangXinTongNing: Interplay between gut microbiota and brain metabolomics in a CUMS mice model, with a focus on tryptophan metabolism
- Deciphering the therapeutic potential of SheXiangXinTongNing: Interplay between gut microbiota and brain metabolomics in a CUMS mice model, with a focus on tryptophan metabolism
- The Interaction between Stress and Inflammatory Bowel Disease in Pediatric and Adult Patients
- Microbiota-brain axis: Exploring the role of gut microbiota in psychiatric disorders - A comprehensive review
- Impact of Transgenerational Nutrition on Nonalcoholic Fatty Liver Disease Development: Interplay between Gut Microbiota, Epigenetics and Immunity
- Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses
- Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies
- Microbial determinants of dementia risk in subjects of Mexican descent with type 2 diabetes living in South Texas
- Gut microbiota composition links to variation in functional domains across psychiatric disorders
- Gut microbiota induced epigenetic modifications in the non-alcoholic fatty liver disease pathogenesis
- Alterations of the gut microbiota in patients with schizophrenia
- The microbiota-gut-brain axis: A crucial immunomodulatory pathway for Bifidobacterium animalis subsp. lactis' resilience against LPS treatment in neonatal rats
- The Gut-Brain Axis in Parkinson's Disease
- The gut microbiome and sociability
- Diet, food, and nutritional exposures and inflammatory bowel disease or progression of disease: an umbrella review
- Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders
- Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications
- The Potential Role of the Ketogenic Diet in Serious Mental Illness: Current Evidence, Safety, and Practical Advice
- Exploring Therapeutic Potential of Phytoconstituents as a Gut Microbiota Modulator in the Management of Neurological and Psychological Disorders
- A comparative study on dietary diversity and gut microbial diversity in children with autism spectrum disorder, attention-deficit hyperactivity disorder, their neurotypical siblings, and non-related neurotypical volunteers: a cross-sectional study
- The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings
- Putative Risk Biomarkers of Bipolar Disorder in At-risk Youth
- Putative Risk Biomarkers of Bipolar Disorder in At-risk Youth
- Nutraceuticals in Psychiatric Disorders: A Systematic Review
- Precision synbiotics increase gut microbiome diversity and improve gastrointestinal symptoms in a pilot open-label study for autism spectrum disorder
- Association of intestinal anti-inflammatory drug target genes with psychiatric Disorders: A Mendelian randomization study
- Utility of zebrafish-based models in understanding molecular mechanisms of neurotoxicity mediated by the gut-brain axis
- Gut microbiota composition in patients with Crohn's disease in Saudi Arabia
- Impact of Synbiotic Intake on Liver Metabolism in Metabolically Healthy Participants and Its Potential Preventive Effect on Metabolic-Dysfunction-Associated Fatty Liver Disease (MAFLD): A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
- Soluble dietary fiber from Dendrocalamus brandisii (Munro) Kurz shoot improves liver injury by regulating gut microbial disorder in mice
- Inflammatory mediators in major depression and bipolar disorder
- Examining the relationship between the oral microbiome, alcohol intake and alcohol-comorbid neuropsychological disorders: protocol for a scoping review
- Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS
- MAFLD as part of systemic metabolic dysregulation
- MAFLD as part of systemic metabolic dysregulation
- Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives
- Gut microbiome predicts cognitive function and depressive symptoms in late life
- Role of the Cerebellum in Bipolar Disorder: A Systematic Literature Review
- Species-level identification of enterotype-specific microbial markers for colorectal cancer and adenoma
- Vascular Dementia: From Pathobiology to Emerging Perspectives
- Peripheral neuronal activation shapes the microbiome and alters gut physiology
- Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial
- Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial
- Critical role of the gut microbiota in immune responses and cancer immunotherapy
- The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence
- Antidepressants in People With Chronic Liver Disease and Depression: When Are They Warranted and How to Choose the Suitable One?
- Adiposity, immunity, and inflammation: interrelationships in health and disease: A report from 24th annual Harvard nutrition obesity symposium, June 2023
- The Sixth Sense: Self-nucleic acid sensing in the brain
- Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations
- The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review
- Hericium erinaceus polysaccharides ameliorate nonalcoholic fatty liver disease via gut microbiota and tryptophan metabolism regulation in an aged laying hen model
- 13C-Stable isotope resolved metabolomics uncovers dynamic biochemical landscape of gut microbiome-host organ communications in mice
- High-fat diet, microbiome-gut-brain axis signaling, and anxiety-like behavior in male rats
- Effects of Active Ingredients in Alcoholic Beverages and Their De-Alcoholized Counterparts on High-Fat Diet Bees: A Comparative Study
- Lactiplantibacillus plantarum ZDY2013 Inhibits the Development of Non-Alcoholic Fatty Liver Disease by Regulating the Intestinal Microbiota and Modulating the PI3K/Akt Pathway
- How Do Mental Disorders and Combinations of Disorders Affect the Odds of Injuries and Poisoning?
- How Do Mental Disorders and Combinations of Disorders Affect the Odds of Injuries and Poisoning?
- Systematic Review: Autism Spectrum Disorder and the Gut Microbiota
- Obstructive respiratory disease in U.S. veterans: Prevalence, characteristics, and health burden
Evidence Blueprint
The Role of the Gut Microbiome in Bipolar Disorder and its Common Comorbidities
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
The Role of the Gut Microbiome in Bipolar Disorder and its Common Comorbidities
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- The gut-brain vascular axis in neuroinflammation
- Can we manage gut microbiome imbalances in patients with bipolar disorder with pharmacotherapy?
- Microbiome-Gut-Mucosal-Immune-Brain Axis and Autism Spectrum Disorder (ASD): A Novel Proposal of the Role of the Gut Microbiome in ASD Aetiology
- Mood disorders: the gut bacteriome and beyond
- The emerging role of the gut microbiome in posttraumatic stress disorder
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Psychobiotics and fecal microbial transplantation for autism and attention-deficit/hyperactivity disorder: microbiome modulation and therapeutic mechanisms
- A comprehensive review on the pharmacological role of gut microbiome in neurodegenerative disorders: potential therapeutic targets
- The brain-gut-microbiota axis in the treatment of neurologic and psychiatric disorders
- The gut microbiota-brain axis in neurological disorder
- Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
- A High-Fat Diet Increases the Characteristics of Gut Microbial Composition and the Intestinal Damage Associated with Non-Alcoholic Fatty Liver Disease
- Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
- Existing and future strategies to manipulate the gut microbiota with diet as a potential adjuvant treatment for psychiatric disorders
- Gut commensal Kineothrix alysoides mitigates liver dysfunction by restoring lipid metabolism and gut microbial balance
- Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson's disease
- Impacts of gut microbiota alteration on age-related chronic liver diseases
- Alterations in fecal virome and bacteriome virome interplay in children with autism spectrum disorder
- Bipolar disorder and the gut microbiota: a bibliometric analysis
- Bipolar disorder and the gut microbiota: a bibliometric analysis
- Sex differences in bipolar disorder: the dorsolateral prefrontal cortex as an etiopathogenic region
- A metagenome-wide association study of gut microbiome in patients with AMD, ASD, RA, T2D & VKH diseases
- Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions
- Gut microbiome composition may be an indicator of preclinical Alzheimer's disease
- Gut and oral microbiome modulate molecular and clinical markers of schizophrenia-related symptoms: A transdiagnostic, multilevel pilot study
- An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders
- Sleep apnoea, gut dysbiosis and cognitive dysfunction
- OBESITY AND GUT-BRAIN AXIS
- The Microbiome in Child and Adolescent Psychiatry
- Dietary fibre confers therapeutic effects in a preclinical model of Huntington's disease
- Correlation between human gut microbiome and diseases
- Platelets bridging the gap between gut dysbiosis and neuroinflammation in stress-linked disorders: A narrative review
- Dysbiotic Gut Microbiota-Derived Metabolites and Their Role in Non-Communicable Diseases
- The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
- Deciphering the therapeutic potential of SheXiangXinTongNing: Interplay between gut microbiota and brain metabolomics in a CUMS mice model, with a focus on tryptophan metabolism
- Deciphering the therapeutic potential of SheXiangXinTongNing: Interplay between gut microbiota and brain metabolomics in a CUMS mice model, with a focus on tryptophan metabolism
- Variety of fruit and vegetables and alcohol intake are associated with gut microbial species and gene abundance in colorectal cancer survivors
- The Interaction between Stress and Inflammatory Bowel Disease in Pediatric and Adult Patients
- Microbiota-brain axis: Exploring the role of gut microbiota in psychiatric disorders - A comprehensive review
- Microbial Reprogramming in Obsessive-Compulsive Disorders: A Review of Gut-Brain Communication and Emerging Evidence
- The identification of metabolites from gut microbiota in coronary heart disease via network pharmacology
- Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: A systematic review of clinical trials
- Gut Microbiome Changes in Anorexia Nervosa: A Comprehensive Review
- Impact of Transgenerational Nutrition on Nonalcoholic Fatty Liver Disease Development: Interplay between Gut Microbiota, Epigenetics and Immunity
- Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses
- The many faces of microbiota-gut-brain axis in autism spectrum disorder
- The importance of the gut microbiome and its signals for a healthy nervous system and the multifaceted mechanisms of neuropsychiatric disorders
- Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies
- Microbial determinants of dementia risk in subjects of Mexican descent with type 2 diabetes living in South Texas
- Gut microbiota composition links to variation in functional domains across psychiatric disorders
- Factors influencing the quality of life in inflammatory bowel disease: A comprehensive review
- The role of gut microbiota in the pathogenesis and treatment of postpartum depression
- Gut microbiota induced epigenetic modifications in the non-alcoholic fatty liver disease pathogenesis
- Behçet Disease and Bipolar Disorder: A Case Report and Review
- Exploring the interplay between posttraumatic stress disorder, gut microbiota, and inflammatory biomarkers: a comprehensive meta-analysis
- Metabolic dysregulation and gut dysbiosis linked to hyperandrogenism in female mice
- Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series
- Alterations of the gut microbiota in patients with schizophrenia
- The microbiota-gut-brain axis: A crucial immunomodulatory pathway for Bifidobacterium animalis subsp. lactis' resilience against LPS treatment in neonatal rats
- The Gut-Brain Axis in Parkinson's Disease
- Gut microbiota bridges the iron homeostasis and host health
- The gut microbiome and sociability
- Diet, food, and nutritional exposures and inflammatory bowel disease or progression of disease: an umbrella review